Journal of Antimicrobial Chemotherapy, Vol 41, 411-415, Copyright © 1998 by The British Society for Antimicrobial Chemotherapy
D Felmingham, MJ Robbins, Y Tesfaslasie, I Harding, S Shrimpton and RN Gruneberg
The antimicrobial susceptibility of 1078 isolates of Haemophilus
influenzae, 348 Streptococcus pneumoniae and 258 Moraxella catarrhalis was
determined. Overall 15.1% of H. influenzae produced beta-lactamase; 98.8%
were susceptible to co-amoxiclav, 85.8% to cefaclor, 96% to clarithromycin
and 100% to ciprofloxacin. The majority (94.2%) of M. catarrhalis produced
beta-lactamase. The overall prevalence of low- level penicillin resistance
(MIC = 0.12-1 mg/L) amongst isolates of S. pneumoniae was 3.4% and that of
high-level resistance (MIC > or = 2 mg/L) was 3.7%. Most (96.3%) of the
isolates of S. pneumoniae were susceptible to amoxycillin (MIC < or =
0.5 mg/L), 96% to cefaclor (MIC < or = 8 mg/L), 90.7% to clarithromycin
(MIC < or = 0.25 mg/L) and 89% to ciprofloxacin (MIC < or = 1 mg/L).
ORIGINAL ARTICLES
Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season
GR Micro Ltd, London, UK. gr.micro@dial.pipex.com
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
I. Morrissey, K. Maher, L. Williams, J. Shackcloth, D. Felmingham, R. Reynolds, and on behalf of the BSAC Working Parties on Resistanc Non-susceptibility trends among Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections in the UK and Ireland, 1999-2007 J. Antimicrob. Chemother., November 1, 2008; 62(suppl_2): ii97 - ii103. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Morrissey, M. Robbins, L. Viljoen, and D. F. J. Brown Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods J. Antimicrob. Chemother., February 1, 2005; 55(2): 200 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cerquetti, M. L. Ciofi degli Atti, G. Renna, A. E. Tozzi, M. L. Garlaschi, P. Mastrantonio, and The Hi Study Group Characterization of Non-Type B Haemophilus influenzae Strains Isolated from Patients with Invasive Disease J. Clin. Microbiol., December 1, 2000; 38(12): 4649 - 4652. [Abstract] [Full Text] |
||||
![]() |
D. F. Sahm, D. E. Peterson, I. A. Critchley, and C. Thornsberry Analysis of Ciprofloxacin Activity against Streptococcus pneumoniae after 10 Years of Use in the United States Antimicrob. Agents Chemother., September 1, 2000; 44(9): 2521 - 2524. [Abstract] [Full Text] |
||||
![]() |
R. A. Seaton, D. T. Steinke, G. Phillips, T. MacDonald, and P. G. Davey Community antibiotic therapy, hospitalization and subsequent respiratory tract isolation of Haemophilus influenzae resistant to amoxycillin: a nested case-control study J. Antimicrob. Chemother., August 1, 2000; 46(2): 307 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Sahm, M. E. Jones, M. L. Hickey, D. R. Diakun, S. V. Mani, and C. Thornsberry Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998 J. Antimicrob. Chemother., April 1, 2000; 45(4): 457 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
Antibiotic treatment of adults with chest infection in general practice DTB, September 1, 1998; 36(9): 68 - 72. [Abstract] [Full Text] [PDF] |
||||



